Pro Share Advisors LLC Neogenomics Inc Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 28,809 shares of NEO stock, worth $270,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,809

Previous 30,041 4.1%

Holding current value

$270,228

Previous $285,000 26.32%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$6.4 - $10.27 $7,884 - $12,652	-1,232 Reduced 4.1%	28,809 $210,000
Q1 2025 May 08, 2025	SELL	$9.09 - $18.61 $76,392 - $156,398	-8,404 Reduced 21.86%	30,041 $285,000
Q4 2024 Feb 13, 2025	BUY	$13.0 - $18.43 $153,803 - $218,045	11,831 Added 44.45%	38,445 $633,000
Q3 2024 Nov 13, 2024	BUY	$13.4 - $17.73 $93,733 - $124,021	6,995 Added 35.65%	26,614 $392,000
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $78,892 - $95,629	-6,064 Reduced 23.61%	19,619 $272,000
Q1 2024 May 08, 2024	BUY	$14.06 - $16.79 $24,815 - $29,634	1,765 Added 7.38%	25,683 $403,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $52,818 - $93,823	4,526 Added 23.34%	23,918 $386,000
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $6,232 - $9,157	-513 Reduced 2.58%	19,392 $238,000
Q2 2023 Aug 10, 2023	BUY	$14.1 - $19.83 $23,180 - $32,600	1,644 Added 9.0%	19,905 $319,000
Q1 2023 May 11, 2023	SELL	$9.09 - $19.45 $14,707 - $31,470	-1,618 Reduced 8.14%	18,261 $317,000
Q4 2022 Feb 02, 2023	BUY	$6.45 - $12.07 $16,634 - $31,128	2,579 Added 14.91%	19,879 $183,000
Q3 2022 Nov 04, 2022	SELL	$7.86 - $12.91 $17,842 - $29,305	-2,270 Reduced 11.6%	17,300 $149,000
Q2 2022 Aug 01, 2022	SELL	$7.06 - $13.97 $62,106 - $122,894	-8,797 Reduced 31.01%	19,570 $159,000
Q1 2022 May 10, 2022	SELL	$12.15 - $35.28 $40,775 - $118,399	-3,356 Reduced 10.58%	28,367 $344,000
Q4 2021 Feb 08, 2022	BUY	$30.49 - $48.49 $338,865 - $538,917	11,114 Added 53.93%	31,723 $1.08 Million
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $500,461 - $630,922	-12,013 Reduced 36.82%	20,609 $994,000
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $4,870 - $6,874	133 Added 0.41%	32,622 $1.47 Million
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $296,904 - $427,782	7,144 Added 28.19%	32,489 $1.57 Million
Q4 2020 Feb 09, 2021	BUY	$36.08 - $56.47 $384,252 - $601,405	10,650 Added 72.47%	25,345 $1.37 Million
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $40,743 - $49,587	-1,225 Reduced 7.69%	14,695 $542,000
Q2 2020 Aug 03, 2020	BUY	$24.21 - $31.02 $209,513 - $268,447	8,654 Added 119.1%	15,920 $493,000
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $174,824 - $294,471	-8,528 Reduced 54.0%	7,266 $201,000
Q4 2019 Feb 12, 2020	BUY	$18.96 - $29.84 $43,702 - $68,781	2,305 Added 17.09%	15,794 $462,000
Q3 2019 Nov 12, 2019	BUY	$19.12 - $26.24 $35,524 - $48,753	1,858 Added 15.97%	13,489 $258,000
Q2 2019 Aug 13, 2019	SELL	$19.57 - $24.1 $273 - $337	-14 Reduced 0.12%	11,631 $255,000
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $141,370 - $238,256	11,645 New	11,645 $238,000

Others Institutions Holding NEO

# of Institutions

307

Shares Held

129M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.18B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Neogenomics Inc Transaction History